BCM
Bayesian Capital Management’s West Pharmaceutical WST Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
+5,900
| New | +$1.29M | 0.2% | 146 |
|
|
2025
Q1 | – | Sell |
-10,500
| Closed | -$3.44M | – | 1008 |
|
|
2024
Q4 | $3.44M | Buy |
+10,500
| New | +$3.44M | 0.42% | 60 |
|
|
2024
Q1 | – | Sell |
-909
| Closed | -$320K | – | 1160 |
|
|
2023
Q4 | $320K | Buy |
909
+281
| +45% | +$98.9K | 0.03% | 488 |
|
|
2023
Q3 | $236K | Buy |
+628
| New | +$236K | 0.03% | 523 |
|
|
2023
Q2 | – | Sell |
-6,000
| Closed | -$2.08M | – | 1094 |
|
|
2023
Q1 | $2.08M | Buy |
+6,000
| New | +$2.08M | 0.26% | 106 |
|
|
2021
Q4 | – | Sell |
-1,197
| Closed | -$508K | – | 538 |
|
|
2021
Q3 | $508K | Buy |
+1,197
| New | +$508K | 0.15% | 186 |
|
|
2021
Q2 | – | Sell |
-845
| Closed | -$238K | – | 677 |
|
|
2021
Q1 | $238K | Sell |
845
-4,455
| -84% | -$1.25M | 0.05% | 412 |
|
|
2020
Q4 | $1.5M | Sell |
5,300
-700
| -12% | -$198K | 0.39% | 64 |
|
|
2020
Q3 | $1.65M | Sell |
6,000
-1,378
| -19% | -$379K | 0.4% | 55 |
|
|
2020
Q2 | $1.68M | Buy |
7,378
+5
| +0.1% | +$1.14K | 0.37% | 56 |
|
|
2020
Q1 | $1.12M | Sell |
7,373
-1,972
| -21% | -$300K | 0.24% | 102 |
|
|
2019
Q4 | $1.41M | Buy |
9,345
+3,500
| +60% | +$526K | 0.24% | 113 |
|
|
2019
Q3 | $829K | Buy |
+5,845
| New | +$829K | 0.16% | 185 |
|
|
2018
Q1 | – | Sell |
-12,400
| Closed | -$1.22M | – | 845 |
|
|
2017
Q4 | $1.22M | Buy |
+12,400
| New | +$1.22M | 0.25% | 129 |
|
|
2017
Q3 | – | Sell |
-6,710
| Closed | -$634K | – | 668 |
|
|
2017
Q2 | $634K | Buy |
+6,710
| New | +$634K | 0.23% | 148 |
|